Eradication of Pseudomonas aeruginosa in cystic fibrosis [6]

European Respiratory Journal

Volumn 27, Issue 2, 2006, Pages 438-439

  Eber, E ^a   Thalhammer, G H ^a   Zach, M S ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COLISTIN; GENTAMICIN; PLACEBO;

ANTIBODY TITER; BACTERIAL COLONIZATION; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; ERADICATION THERAPY; GENOTYPE; GRAM NEGATIVE INFECTION; HIGH RISK PATIENT; HUMAN; IMMUNE RESPONSE; LETTER; LONG TERM CARE; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; SPUTUM CULTURE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LUNG; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECURRENCE; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 31844432588     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00118805     Document Type: Letter

References (6)

1. Taccetti G, Campana S, Festini F, Mascherini M, Döring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005; 26: 458-461.
2. Jones AM. Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered. Eur Respir J 2005; 26: 373-375.
3. Thalhammer GH, Pratl B, Eber E, Zach MS. Pseudomonas aeruginosa in patients with cystic fibrosis: a comparison of early eradication and conventional therapy. Eur Respir J 2004; 24: Suppl. 48, 385s-386s.
4. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Olinsky A, Phelan PD. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996; 21: 267-275.
5. Döring G, Høiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 1983; 42: 197-201.
6. Heinzl B, Eber E, Oberwaldner B, Haas G, Zach MS. Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study. Pediatr Pulmonol 2002; 33: 32-37.